T. Rowe Price Associates’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.9M Sell
673,171
-241,910
-26% -$5.37M ﹤0.01% 1028
2025
Q1
$17M Sell
915,081
-9,926
-1% -$185K ﹤0.01% 992
2024
Q4
$12.2M Buy
925,007
+1,890
+0.2% +$25K ﹤0.01% 1106
2024
Q3
$30.9M Buy
923,117
+622,893
+207% +$20.9M ﹤0.01% 883
2024
Q2
$7.53M Buy
300,224
+128,535
+75% +$3.22M ﹤0.01% 1150
2024
Q1
$3.87M Sell
171,689
-60,065
-26% -$1.35M ﹤0.01% 1297
2023
Q4
$4.97M Buy
231,754
+5,472
+2% +$117K ﹤0.01% 1208
2023
Q3
$4.07M Buy
+226,282
New +$4.07M ﹤0.01% 1217
2023
Q1
Sell
-12,579
Closed -$390K 2924
2022
Q4
$390K Buy
12,579
+320
+3% +$9.92K ﹤0.01% 2258
2022
Q3
$313K Buy
12,259
+1,276
+12% +$32.6K ﹤0.01% 2355
2022
Q2
$223K Buy
10,983
+111
+1% +$2.25K ﹤0.01% 2548
2022
Q1
$269K Buy
10,872
+475
+5% +$11.8K ﹤0.01% 2583
2021
Q4
$361K Buy
10,397
+2,257
+28% +$78.4K ﹤0.01% 2525
2021
Q3
$221K Sell
8,140
-126
-2% -$3.42K ﹤0.01% 2680
2021
Q2
$214K Sell
8,266
-1,514
-15% -$39.2K ﹤0.01% 2698
2021
Q1
$211K Sell
9,780
-323,124
-97% -$6.97M ﹤0.01% 2667
2020
Q4
$7.16M Buy
+332,904
New +$7.16M ﹤0.01% 1391
2019
Q4
Sell
-864,204
Closed -$30.2M 2521
2019
Q3
$30.2M Sell
864,204
-73,069
-8% -$2.56M ﹤0.01% 1029
2019
Q2
$52.9M Buy
937,273
+147,292
+19% +$8.31M 0.01% 866
2019
Q1
$57.7M Buy
789,981
+364,593
+86% +$26.6M 0.01% 818
2018
Q4
$27.1M Buy
425,388
+38,919
+10% +$2.48M ﹤0.01% 1049
2018
Q3
$38.6M Sell
386,469
-48,759
-11% -$4.86M 0.01% 1011
2018
Q2
$30.9M Buy
435,228
+233,748
+116% +$16.6M ﹤0.01% 1060
2018
Q1
$21M Buy
201,480
+92,383
+85% +$9.62M ﹤0.01% 1163
2017
Q4
$11M Buy
+109,097
New +$11M ﹤0.01% 1311